Contact Us
Categories
- Part 2
- Data Privacy
- Department of Health and Human Services' Office of Civil Rights
- Medical Malpractice
- Medical Cannabis
- Workplace health
- Workplace Violence
- Assisted Living Facilities
- EMTALA
- FDA
- Reproductive Rights
- Roe v. Wade
- SCOTUS
- COVID-19
- Prescription Drugs
- Telemedicine
- Medical Spas
- Code Enforcement
- Corporate
- United States Department of Justice ("DOJ")
- Employee Contracts
- Non-Compete Agreement
- Compliance
- HIPAA
- Kentucky Board of Nursing
- Managed Care Organizations (“MCOs”)
- KASPER
- Kentucky’s Department for Medicaid Services
- Mental Health Care
- Primary Care Physicians ("PCPs")
- Accountable Care Organizations (“ACO”)
- Affordable Care Act
- Anti-Kickback Statute
- APRNs
- Centers for Medicare & Medicaid Services (“CMS”)
- Charitable Hospitals
- Data Breach
- Electronic Protected Health Information (ePHI)
- False Claims Act
- Federally Qualified Health Centers (“FQHCs”)
- Health Information Technology for Economic and Clinical Health Act (HITECH Act)
- Health Insurance Portability and Accountability Act of 1996 (HIPAA)
- Health Professional Shortage Area ("HPSA")
- Hospitals
- HPSA
- HRSA
- Kentucky Board of Medical Licensure
- Medicaid
- Medicare
- Mid-Level Practitioners
- Office for Civil Rights ("OCR")
- Office of Inspector General of the United States Department of Health and Human Services (OIG)
- Patient Protection and Affordable Care Act (“ACA”)
- Pharmacists
- Physician Assistants
- Qui Tam
- Rural Health Centers (“RHCs”)
- Rural Health Clinic
- Stark Laws
- Telehealth
- Fraud
- Part D
- Business Associate Agreements
- Compliance Programs
- Electronic Health Records (“EHR")
- ERISA
- Hospice
- Overpayments
- Appeal
- Business Associates
- Denied Claims
- Division of Regulated Child Care
- Employee Agreement
- Fair Labor Standards Act (FLSA)
- Licensed practical nurses (LPN)
- Licensure Requirements
- Nurse practitioners (NP)
- Part A
- Part B
- Personal Health Information
- Personal Service Entities
- Physician Payments
- Qualified Health Plan ("QHP")
- Registered nurses (RN)
- Abuse and Waste
- Advanced Practice Registered Nurses
- Occupational Safety and Health Administration (“OSHA”)
- Patient Autonomy
- Department of Health and Human Services (HHS)
- Health Care Law
- Health Insurance
- Healthcare Regulation
McBrayer Blogs
Complying with KASPER
The Kentucky General Assembly passed House Bill 1, also known as the “pill mill bill” in 2012. Following its enactment, the Cabinet for Health and Family Services and various licensure boards issued regulations implementing its requirements. It was soon realized that the law would need some refinement to address concerns raised by the provider community and stakeholders. In 2013, House Bill 217 amended portions of House Bill 1 to address some unintended consequences of the original legislation. One of those amendments was giving an exemption to hospitals, long-term care facilities and approved researchers from the law’s requirement to report controlled substances administered directly to patients through the state’s description drug monitoring system, KASPER. However, for those licensees not exempt from the reporting, it remains a stringent requirement that a KASPER report is filed within one day of dispensing a controlled substance. (See more on HB 217 here.)
Complying with KASPER can be tedious, to say the least. But, there are some common sense tips that, when utilized, can make the system run more smoothly. Here are some pointers for prescribers:[1]
1. Distinguish yourself.
If you work alongside multiple prescribers and the prescription pad is pre-printed with the names and DEA numbers of everyone in the practice, you will need to specify who is actually prescribing. You can do this by circling your name and DEA number in the pre-printed area or by clearly printing your name, DEA number and/or state license number alongside your signature.
2. Identify the patient.
It goes without saying that the patient’s name should be on the prescription, but double-check to make sure you are including their full name and any suffixes (Sr., Jr., III, etc.). Any incident of fraud can be further reduced by including the patients’ date of birth, address and Social Security Number. The more information, the better.
3. Do not pre-sign or post-date.
Title 21 in the Code of Federal Regulations §1306.05(a) clearly directs that “all prescriptions for controlled substances shall be dated as of, and signed on, the day when issued…”. An office staff member cannot complete a pre-signed or post-dated prescription at a later time.
4. Clarify acetaminophen strength.
Manufacturers have until January 14, 2014 to remove prescription medications containing more than 325mg of acetaminophen per tablet/capsule from the market, in line with the Food and Drug Administration’s directive. Combination products are now hitting the market, with various strengths of acetaminophen under the 325mg limit. If you prescribe one of these combination products, include the strength of the acetaminophen. Failure to do so will lead to a phone call requesting the correct mg.
There are many state and federal statutes and regulations that govern controlled substances. If you have a question about any of these, you can always call your licensing board, DEPPB, or the DEA. You can also contact one of the health care attorneys at McBrayer. If you have ever received a KASPER report and been perplexed about some of the information included therein, check back on Thursday and I’ll offer some tips for decoding it.
[1] This guidance was originally provided in the Fall 2013 Kentucky Board of Medical Licensure Newsletter by Amanda J. Ward of the Drug Enforcement and Professional Practices Branch.
Services may be performed by others.
This article does not constitute legal advice.

